• 2023-05-22

    VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM17 ACCEPTED BY NMPA CDE

  • 2023-05-03

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023

  • 2023-04-26

    INSIDE INFORMATION PHASE III CLINICAL STUDY OF SM03 (SUCIRASLIMAB) IN RHEUMATOID ARTHRITIS MEETS PRIMARY ENDPOINT

  • 2023-04-26

    NOTICE OF 2023 ANNUAL GENERAL MEETING

  • 2023-04-26

    FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 6, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON MONDAY, 12 JUNE 2023 AT 10:00 A.M.

  • 2023-04-26

    PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

  • 2023-04-26

    Annual Report 2022

  • 2023-04-04

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023